4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-036698
Chief Research Officer acquired 5,571 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Grigoriadis Dimitri E. · Chief Research Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-11 | Exercise or conversion : show line 1 in the form | +2,710 | $32.99 | $89,403 | 74,702 | D |
| 2020-06-11 | Exercise or conversion : show line 2 in the form | +1,812 | $35.99 | $65,214 | 76,514 | D |
| 2020-06-11 | Exercise or conversion : show line 3 in the form | +1,049 | $43.24 | $45,359 | 77,563 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-11 | Exercise or conversion : show line 4 in the form Incentive Stock Option | −2,710 | $32.99 | $89,403 | $32.99 | 2025-02-03 | 2,710 | 0 | D |
| 2020-06-11 | Exercise or conversion : show line 5 in the form Incentive Stock Option | −1,812 | $35.99 | $65,214 | $35.99 | 2026-02-05 | 1,812 | 0 | D |
| 2020-06-11 | Exercise or conversion : show line 6 in the form Incentive Stock Option | −1,049 | $43.24 | $45,359 | $43.24 | 2027-02-06 | 1,049 | 2,151 | D |
Loading xslF345X03/doc4.xml…